Note: Assignment of patients to drug groupings is based on the latest drug taken by the patient, except in one patient who was on warfarin but who took apixaban for two days, and another who was on warfarin but took rivaroxaban for one day.
* Inter-quartile range
Non-steroidal anti-inflammatory drugs (NSAIDs) included for analysis were “aspirin”, “celecoxib”, “diclofenac”, “etoricoxib”, “ibuprofen”, “indomethacin”, “ketoprofen”, “mefenamic acid”, “meloxicam”, “naproxen”, “piroxicam”
Antiplatelet drugs included for analysis were “dipyridamole”, “eptifibatide”, “prasugrel”, “ticagrelor”, “ticlopidine”
§ Based on earlier event if patient had records of both bleeding and thromboembolic events
Table 3. Clinical characteristics of the final cohort (unique n = 132)